HomeWellness Articles › GLP-1 Weight Loss Boca Raton

★★★★★ 4.9 Google Rating⚕ Physician-Led · Every Protocol🧪 Advanced Labs · Full Panel📍 Boca Raton · 17+ Yrs
Quick Answer: Tirzepatide (Zepbound) achieves up to 20.9% body weight reduction vs. 14.9% for semaglutide (Wegovy) in clinical trials. Brazelia Med Spa in Boca Raton offers physician-supervised GLP-1 programs with full metabolic monitoring — no templates, no telehealth shortcuts.
20.9%Avg. weight loss with tirzepatide (SURMOUNT-1)
14.9%Avg. weight loss with semaglutide (STEP-1)
47%More weight lost with tirzepatide vs. semaglutide head-to-head
2xHormone targets: GIP + GLP-1 vs. GLP-1 alone

What Are GLP-1 Medications & How Do They Work?

GLP-1 weight loss medications work by mimicking glucagon-like peptide-1, a hormone your gut naturally releases after eating. At therapeutic doses, these medications suppress appetite at the brain level, slow gastric emptying, improve insulin sensitivity, and reduce food cravings — producing weight loss that far exceeds what diet and exercise alone can achieve in most patients.

The two leading medications are semaglutide (Ozempic for diabetes, Wegovy for weight loss) and tirzepatide (Mounjaro for diabetes, Zepbound for weight loss). Tirzepatide is the newer, more effective option — it activates both GIP and GLP-1 receptors, producing a dual hormonal effect that consistently outperforms semaglutide in clinical trials.

✔ Key Takeaways

  • GLP-1 medications reduce hunger neurologically — patients report genuinely not feeling hungry, not willpower-driven restriction
  • Tirzepatide activates two hormone receptors (GIP + GLP-1); semaglutide activates one — producing superior weight loss
  • Physician supervision, proper titration, and metabolic monitoring are essential for safety and best outcomes
  • These are FDA-approved prescription medications with extensive Phase 3 clinical trial data — not supplements

Tirzepatide vs. Semaglutide: 2025 Clinical Data Compared

The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) demonstrated tirzepatide 15mg achieving 20.9% mean body weight reduction over 72 weeks — a result previously seen only with bariatric surgery. For a 250 lb patient, that’s approximately 52 lbs. The STEP-1 trial for semaglutide 2.4mg showed 14.9% reduction — still clinically significant, but meaningfully lower. Head-to-head data from SURMOUNT-5 confirmed tirzepatide produced 47% more weight loss than semaglutide at equivalent duration.

FactorTirzepatide (Zepbound)Semaglutide (Wegovy)
MechanismDual GIP + GLP-1 agonistGLP-1 agonist only
Avg. Weight Loss20.9% (SURMOUNT-1)14.9% (STEP-1)
FDA Approval for Weight LossZepbound — Nov 2023Wegovy — June 2021
DosingWeekly injection; 2.5mg–15mgWeekly injection; 0.25mg–2.4mg
Cardiovascular BenefitYes (SURPASS-CVOT data)Yes (SELECT trial)
Brand Cost (monthly)~$900–$1,100~$900–$1,350
Compounded optionAvailable at BrazeliaAvailable at Brazelia

What Results Can You Realistically Expect?

Results depend on starting weight, metabolic health, adherence, protein intake, and exercise. Based on clinical trial data and real-world patient outcomes, here is a typical tirzepatide timeline:

📅 Typical Result Timeline — Tirzepatide at Brazelia

  • Weeks 1–4 (2.5mg): Mild appetite reduction, GI adjustment. Average 2–4 lbs lost.
  • Weeks 5–8 (5mg): Noticeable appetite suppression, cravings reduced. 1–2 lbs/week typical.
  • Months 3–6: Peak weight loss velocity. Most patients lose 12–18 lbs in this window.
  • Months 6–12: Dose optimization, plateau management. Total loss typically 15–22%.
  • Year 2+: Maintenance dosing. Continued metabolic, cardiovascular, and body composition benefit.

Important: stopping the medication without a structured transition plan typically results in weight regain within 12 months. Brazelia’s program includes a maintenance protocol to preserve long-term results.

Who Qualifies for GLP-1 Weight Loss in Boca Raton?

FDA approval guidelines require a BMI of 30+ (obese) or BMI 27+ with at least one weight-related health condition — hypertension, Type 2 diabetes, high cholesterol, or sleep apnea. our physician evaluates each patient individually and may extend benefit to patients with BMI 25–27 with significant metabolic syndrome on a case-by-case basis.

Your initial consultation at Brazelia includes a comprehensive medical history review, current medications, lab panel, and discussion of your goals. This is a thorough physician-led evaluation — not a quick prescription visit.

Ready to Start Your GLP-1 Program in Boca Raton?

Schedule a physician consultation with our team at Brazelia Med Spa. Review your labs, health history, and goals — then receive a personalized protocol designed for you.

Book Your Consultation →

How Brazelia Med Spa’s GLP-1 Program Works

Every patient is managed by our team at Brazelia Med Spa — Board-Certified in DOM with advanced training in hormone optimization, metabolic medicine, and integrative wellness. This is not a telehealth platform. Every protocol is personalized.

  1. Initial Consultation + Labs: Comprehensive metabolic panel, HbA1c, thyroid, lipid panel, kidney/liver function, full hormone assessment.
  2. Personalized Dosing: Slow titration protocol minimizes side effects and improves adherence.
  3. Monthly Check-ins: Body composition, labs, appetite feedback, medication adjustments.
  4. Nutritional Guidance: Protein optimization (0.8–1g/lb lean mass), micronutrient support, meal timing for muscle preservation.
  5. Maintenance Planning: Structured weaning, habit consolidation, and continued metabolic support.

We offer brand-name Zepbound and Wegovy, plus compounded tirzepatide and semaglutide from FDA-registered 503B pharmacies for patients who need affordable alternatives.

Side Effects, Risks & How We Manage Them

The most common side effects are gastrointestinal — nausea, reduced appetite, loose stools. These are dose-dependent and typically resolve within 2–4 weeks of each dose increase. Brazelia’s slow titration protocol is designed to minimize these.

Side EffectFrequencyManagement
Nausea30–44% (mild-moderate)Slow titration, small meals, anti-nausea if needed
Constipation~25%Fiber, hydration, magnesium supplementation
Injection site reaction~5%Site rotation, proper technique training
Muscle lossPossible without interventionResistance training, protein targets, hormone support
Pancreatitis (rare)<0.1%Contraindicated with personal/family hx of MEN2

Absolute contraindications: personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN2). our physician screens every patient before prescribing.

Cost, Insurance & Compounded Options

Brand-name GLP-1 medications cost approximately $900–$1,350/month without insurance. Coverage varies significantly by plan. Compounded tirzepatide and semaglutide are available at Brazelia for $200–$400/month from licensed 503B pharmacies — a substantially more affordable option for many patients. We help patients navigate prior authorization and insurance appeals when appropriate.

Frequently Asked Questions

Is tirzepatide better than semaglutide for weight loss?

Yes, based on consistent clinical evidence. SURMOUNT-1 showed 20.9% body weight reduction for tirzepatide 15mg vs. 14.9% for semaglutide 2.4mg in STEP-1. Head-to-head data (SURMOUNT-5) confirmed tirzepatide produced 47% more weight loss than semaglutide. Both medications are effective; individual responses vary.

How long do I need to stay on GLP-1 medications?

GLP-1 medications are generally not short-term. Clinical data shows patients who stop regain most weight within 12 months without lifestyle consolidation. Many patients continue at a maintenance dose indefinitely. Our physicians creates individualized exit strategies when stopping is appropriate.

Does Brazelia Med Spa offer compounded semaglutide or tirzepatide?

Yes. We offer compounded tirzepatide and semaglutide from licensed 503B compounding pharmacies during FDA shortage periods and for patients who cannot afford brand-name pricing. Compounded medications are not FDA-approved finished products; we explain all differences at consultation.

Will I lose muscle mass on GLP-1 medications?

Without intervention, 25–40% of total weight lost may come from lean mass. Brazelia’s program specifically addresses this: personalized protein targets (0.8–1g/lb lean mass), resistance training guidance, hormone panel review, and peptide therapy options for muscle preservation.

Can I get GLP-1 medications quickly in Boca Raton?

Yes. Brazelia offers same-week and next-week consultations. We are not a telehealth platform — every patient receives an in-person or telemedicine consultation before any prescription. We have established pharmacy relationships to minimize delays.

What does a GLP-1 consultation at Brazelia cost?

Contact us for current pricing — we offer program tiers depending on monitoring frequency and included services. Financing available through CareCredit. Call 561.353.2265 or book online.

★★★★★ 4.9 Google Rating⚕ Physician-Led · Every Protocol🧪 Advanced Labs · Full Panel📍 Boca Raton · 17+ Yrs

Start Your Medical Weight Loss Journey Today

Brazelia Med Spa is Boca Raton’s physician-led medspa offering integrated GLP-1 weight loss with hormone optimization, body composition analysis, and full metabolic monitoring.

Schedule Your Consultation →
our team at Brazelia Med Spa ND DOM - PHYSICIAN-LED MEDICAL CONTENT | REVIEWED BY LICENSED PRACTITIONERS<div>
<p class=Brazelia Med Spa Editorial Team

PHYSICIAN-LED MEDICAL CONTENT | REVIEWED BY LICENSED PRACTITIONERS

The Brazelia Med Spa Editorial Team creates physician-reviewed content on integrative wellness, hormone optimization, medical weight loss, and longevity medicine. All articles are reviewed by licensed practitioners at Brazelia Med Spa in Boca Raton, FL.Meet our full medical team or learn more about our team →

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications require physician evaluation and prescription. Individual results vary. Content reviewed by the Brazelia Med Spa team. Consult a qualified healthcare provider before starting any treatment.

References & Citations

  1. Jastreboff AM, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” NEJM. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
  2. Wilding JPH, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” NEJM. 2021;384:989-1002. doi:10.1056/NEJMoa2032183
  3. Lincoff AM, et al. “Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.” NEJM. 2023;389:2221-2232. doi:10.1056/NEJMoa2307563
  4. FDA. “FDA Approves New Medication for Chronic Weight Management.” November 2023. fda.gov
  5. Obesity Medicine Association. “Obesity Algorithm 2025.” obesitymedicine.org
Tagged , , , , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

BOOK NOW